<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen D</submitter><funding>National Key R&amp;D Program of China</funding><pagination>2804</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11943016</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(6)</volume><pubmed_abstract>In previous studies, we isolated a series of novel gentisides with nerve growth factor (NGF)-mimic activities from &lt;i>Gentiana rigescens&lt;/i> Franch and conducted continuous structure-activity relationship (SAR) studies. Recently, a lead compound named TBG096 was discovered with significant NGF-mimic activity, low toxicity, and ability to pass through the blood-brain barrier (BBB). At the cell level, TBG096 exerts NGF-mimic activity by regulation of heat-shock cognate protein 70 (Hsc70) and downstream proteins. Subsequently, high-fat diet (HFD)-induced Alzheimer disease (AD) mouse models were used to evaluate the anti-AD efficacy of the compound. TBG096 significantly improved the memory dysfunction of AD mice at doses of 0.1, 5, and 20 mg/kg, respectively. In order to elucidate the mechanis</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>TBG096 Ameliorates Memory Deficiency in AD Mouse Model via Promoting Neurogenesis and Regulation of Hsc70/HK2/PKM2/LAMP2A Signaling Pathway.</pubmed_title><pmcid>PMC11943016</pmcid><funding_grant_id>2022YFE0104000</funding_grant_id><pubmed_authors>Fasina OB</pubmed_authors><pubmed_authors>Qi J</pubmed_authors><pubmed_authors>Zeng J</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Manzoor M</pubmed_authors><pubmed_authors>Ohno H</pubmed_authors><pubmed_authors>Xiang L</pubmed_authors><pubmed_authors>Chen D</pubmed_authors></additional><is_claimable>false</is_claimable><name>TBG096 Ameliorates Memory Deficiency in AD Mouse Model via Promoting Neurogenesis and Regulation of Hsc70/HK2/PKM2/LAMP2A Signaling Pathway.</name><description>In previous studies, we isolated a series of novel gentisides with nerve growth factor (NGF)-mimic activities from &lt;i>Gentiana rigescens&lt;/i> Franch and conducted continuous structure-activity relationship (SAR) studies. Recently, a lead compound named TBG096 was discovered with significant NGF-mimic activity, low toxicity, and ability to pass through the blood-brain barrier (BBB). At the cell level, TBG096 exerts NGF-mimic activity by regulation of heat-shock cognate protein 70 (Hsc70) and downstream proteins. Subsequently, high-fat diet (HFD)-induced Alzheimer disease (AD) mouse models were used to evaluate the anti-AD efficacy of the compound. TBG096 significantly improved the memory dysfunction of AD mice at doses of 0.1, 5, and 20 mg/kg, respectively. In order to elucidate the mechanis</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-07-02T03:04:46.55Z</modification><creation>2025-07-02T03:04:46.55Z</creation></dates><accession>S-EPMC11943016</accession><cross_references><pubmed>40141445</pubmed><doi>10.3390/ijms26062804</doi></cross_references></HashMap>